Filing Details

Accession Number:
0001144204-15-060242
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-10-21 16:31:09
Reporting Period:
2015-10-19
Filing Date:
2015-10-21
Accepted Time:
2015-10-21 16:31:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369868 China Biologic Products Inc. CBPO Biological Products, (No Disgnostic Substances) (2836) 752308816
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1331795 David Gao 18Th Floor, Jialong International
Building, 19 Chaoyang Park Road
Beijing F4 100125
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-10-19 200 $105.03 616,800 No 4 S Direct
Common Stock Disposition 2015-10-20 258 $105.00 616,542 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents 458 shares of common stock sold through a trading plan (the "10b5-1 Plan") adopted by the Reporting Person on September 14, 2015 that complies with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended. The Reporting Person intends to use the proceeds from the sales effected under the 10b5-1 Plan to pay income tax due in connection with the scheduled vesting of certain restricted stock held by the Reporting Person and the exercise of certain stock options held by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $105.020 to $105.030, inclusive. The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Footnote 2.